CRNX
Crinetics Pharmaceuticals Inc
85.00$
+0.0%
vs. previous close
Closing price · As of: Sep 2, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Crinetics Pharmaceuticals Inc (CRNX) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/01/2026 | Current report (8-K) | Crinetics Pharmaceuticals, Inc. (CRNX): Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Material Modifications to Rights of Security Holders; Changes in Control of Registrant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles o | View report ↗ |
| 08/28/2026 | Current report (8-K) | Crinetics Pharmaceuticals, Inc. (CRNX): Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View report ↗ |
| 08/19/2026 | Current report (8-K) | Crinetics Pharmaceuticals, Inc. (CRNX): Other Events | View report ↗ |
| 08/14/2026 | Current report (8-K) | Crinetics Pharmaceuticals, Inc. (CRNX): Other Events | View report ↗ |
| 08/03/2026 | Current report (8-K) | Crinetics Pharmaceuticals, Inc. (CRNX): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 07/10/2026 | Current report (8-K) | Crinetics Pharmaceuticals, Inc. (CRNX): Entry into a Material Definitive Agreement; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers | View report ↗ |
| 07/06/2026 | Current report (8-K) | Crinetics Pharmaceuticals, Inc. (CRNX): Entry into a Material Definitive Agreement; Other Events; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.